Contrast MRA reduces cost for PVD diagnosis

Article

The Veterans Affairs system could have saved more than $13 million in six years by using contrast-enhanced MR angiography instead of digital subtraction angiography for peripheral vascular disease imaging, according to a multicenter study presented at the 2006 International Society of Pharmacoeconomics and Outcomes Research meeting.

The Veterans Affairs system could have saved more than $13 million in six years by using contrast-enhanced MR angiography instead of digital subtraction angiography for peripheral vascular disease imaging, according to a multicenter study presented at the 2006 International Society of Pharmacoeconomics and Outcomes Research meeting.

J.W. Hay, Ph.D., an associate professor of pharmaceutical economics and policy at the University of Southern California, retrospectively reviewed VA outpatient data on almost 20,000 patients who underwent DSA and CE-MRA from 1999 to 2004. He found that use of CE-MRA reduced imaging costs by 55% over DSA. Costs per procedure were reduced by $950 compared with DSA.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Related Content
© 2025 MJH Life Sciences

All rights reserved.